21812668

Source:http://linkedlifedata.com/resource/pubmed/id/21812668

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C1555720, umls-concept:C2728259
pubmed:issue	5
pubmed:dateCreated	2011-8-4
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Agents
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1533-4406
pubmed:author	pubmed-author:KozlowskiStevenS, pubmed-author:MidthunKarenK, pubmed-author:ShermanRachel BehrmanRB, pubmed-author:WoodcockJanetJ
pubmed:issnType	Electronic
pubmed:day	4
pubmed:volume	365
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	385-8
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:21812668-Biological Agents, pubmed-meshheading:21812668-Government Regulation, pubmed-meshheading:21812668-Legislation, Drug, pubmed-meshheading:21812668-Molecular Structure, pubmed-meshheading:21812668-Therapeutic Equivalency, pubmed-meshheading:21812668-United States, pubmed-meshheading:21812668-United States Food and Drug Administration
pubmed:year	2011
pubmed:articleTitle	Developing the nation's biosimilars program.
pubmed:affiliation	U.S. Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.
pubmed:publicationType	Journal Article